Idorsia

#Cardiovascular disease #FDA #Hypertension #Idorsia #Phase II trial

FDA approval represents ‘transformational progress’ in hypertension

The US Food and Drug Administration (FDA) has approved Tryvio (aprocitentan) for the treatment of hypertension in combination with other antihypertensive drugs, to lower blood pressure in adult patients who are not adequately controlled on other drugs. Tryvio (aprocitentan) is an endothelin receptor antagonist that inhibits the binding of endothelin… Read More

#News #Regulatory #Trending News